The Evidence Life Science Videos Library is the full collection of video recordings (and supporting documentation) from all Evidence Life Science events.
Tessa Pugh
CEO
PharmaReview
Caroline Halford
Development Director for Medical Education
Springer Healthcare
David Braca
Regional Sales Director - US
Springer Healthcare
Samin Saeed
Chief Medical Officer
PharmaReview
Luke Rogers
Senior Director, Business Partnerships
Within3
Joaquin Casariego
Senior Advisor
Savana
Gemma Allen
Expert in Technology Innovation
Open Health
Oliver Childs
Expert in Creative Scientific Communications
Open Health
Chris Bassett
Sales Director
Springer Healthcare
Simon Fry
Digital Product Development Director
Springer Healthcare
Chris Rolfe
Consultant, Real-World Evidence
Open Health
Looking at the full universe of patients, leveraging surrogate endpoints, clustering poor responders,
Considering the durability of the effect, conducting indirect treatment comparisons, understanding unmet needs - In summary, improving data packages while reducing uncertainty.
All that is a step closer if you apply AI to RWE generation, pulling the information directly from healthcare providers, without intermediaries.
We are talking about a database, a registry, a CRF... with an "undo button"; at a fraction of the effort.
Ignacio Medrano
Founder & Chief Medical Officer
Savana
Tessa Pugh
CEO
PharmaReview
Ignacio Medrano
Founder & Chief Medical Officer
Savana
Nina Levin
Vice President - Client Success
Within3
James Turnbull
Global Head of Omnichannel Communications
OPEN Health
Jenny Ghith
Senior Director, Omnichannel Strategy and Innovation Lead, Global Scientific Communications
Pfizer Oncology
The remit for Medical Affairs is extensive with a key objective of gathering actionable insights into clinician behaviour to identify practice and prescription patterns—and the rationales behind physician choices. Join us to learn more about closing knowledge gaps to maximize the impact of your medical activities.
Christina Hoffman
Global Head, Medscape Medical Affairs
Medscape Medical Affairs
Let's take the idea of KOL engagement a bit further! Discover how to bridge the knowledge gap in multiple communities by sharing scientific information with relevant stakeholders simultaneously thus leveraging existing networks, relationships, and channels to foster connections. Join us in exploring the ideas and hear a few practical real-life cases of community engagement.
Iola Forster
Strategic Competence Lead, Industry & Society Services
Karger Publishers
Geoff Covey
General Manager, Karger UK
Karger Publishers
Tim Murphy
Senior Director of Client Partnerships
Within3
As the industry continues to rethink the profile of medical affairs, it must seek out new competencies, technology solutions, and data sources that better support patient-centric outcomes. Medical affairs leaders are at the forefront of this evolution and newly positioned to rewrite the traditional corporate formula for success. Understanding and analysing the scientific share of voice of competitive compounds has become increasingly critical when evolving commercialisation strategies. These highly specific insights create a foundation for continuous improvements and opportunities to act with greater focus. These efforts allow teams to accurately benchmark external relations and inform strategic engagement.
As innovation increases the complexity of care and the scientific demand of the treating community grows, the ability to identify and engage community leaders using insights from medical claims data is now critical for long-term success.
Robert Groebel
Vice President - Global Medical Strategy
Monocl
Traditional methods of evidence generation from electronic health records are no longer fit for purpose. Discover how AI techniques such as clinical natural language processing (cNLP) can generate deep RWE to deliver clinical and economic value for industry. Hear about:
· The limitations of traditional methods of evidence generation from electronic health records
· The benefits of AI-based techniques such as cNLP
· A gold standard for high-quality RWE for deeper insights at scale and speed
· Ideas for applying deep RWE across the Pharma R&D and commercial lifecycle
Ignacio Medrano
Founder & Chief Medical Officer
Savana
Luke Rogers
Senior Director, Business Partnerships
Within3
Rosie Humphreys
Digital Communications Director
Open Health
Traditional methods alone for evidence generation in electronic health records are no longer fit for purpose. We discuss how AI applied to electronic health records for Deep RWE, at scale and speed, can generate greater scientific and economic value for Medical Affairs:
Ignacio Medrano
Founder & Chief Medical Officer
Savana
Jessica Ingram
Senior Vice President, Learning & Development
OPEN Health Medical Communications
Sophie Officer-Thorley
Senior Account Manager - Learning and Development
OPEN Health Medical Communications
The remit for Medical Affairs is extensive with a key objective of gathering actionable insights into clinician behaviour to identify practice and prescription patterns—and the rationales behind physician choices. Join us to learn more about closing knowledge gaps to maximize the impact of your medical activities.
Christina Hoffman
Global Head, Medscape Medical Affairs
Medscape Medical Affairs
Steven Gomez
Solutions Design Director
Monocl
Luke Rogers
Senior Director, Business Partnerships
Within3
Innovation in an already crowded oncology space has created a challenge for medical affairs. The proliferation of compounds in development has reinforced the need to accurately identify strategic opportunities, address the scientific need of experts, while continuously demonstrating value. To achieve these goals, medical leaders must develop clear, comprehensive insights. With an immense amount of data at their disposal, medical affairs must develop novel approaches to leverage this information to inform targeted decisions and investments.
Robert Groebel
Vice President - Global Medical Strategy
Monocl
Jeffrey Saffer
CEO and Co-founder
Quertle
Chahrazed Poignant
Business Development Manager
Karger
Gregor Bangert
Regional Manager
Karger
Tony Cox
Development Director Real-World Evidence
OPEN Health
Recent advances in AI such as clinical natural language processing (NLP) and Machine Learning are enabling the mining of data from the EMR across multiple sites and in multi-languages enabling new insights and accelerating innovation.
Ignacio Medrano
Founder & Chief Medical Officer
Savana
Learn about the power of patient insights and discover real-world patients' insights generation. Understand the value of patients' insights at each step of a product's lifecycle from Target product profiling to Preference study, through Clinical trial optimization and patient's experience (disease and treatment management, unmet needs..).
Carine Odouard
Global Business Development Director - Head of Real World Evidence
Carenity - EvidentIQ Group
Julya Zuenkova
Business Development Director
Xstrahl Group
COVID-19 significantly impacted how providers reach out to patients. Besides, there has been a series of changes in the reimbursement and funding of medical technologies and procedures. These aspects created opportunities to address new market needs and leverage data and learning to deliver more value to a growing network of payers, providers, and patients. Welcome to the new era of Network Value.
Ernesto M. Nogueira
CEO and Founder
ValueConnected
Claus Schaffrath
Managing Director, MD squared
Katarzyna Kolasa
Sr. Consultant Health Economics, MD squared
Professor & Head of Health Economics & Healthcare Management Division, Kozminski University
In today's demanding world of national requirements, how can companies develop the right evidence portfolio to succeed? How can they integrate evidence for payers with their regulatory studies? This in depth review will discuss core principles in evidence development for diagnostics and therapeutic medical devices, and how these concepts can align with the requirements of the major global markets -- the UK, France, Germany, Japan and the USA. Learn about the evolving landscape of evidence demands in:
Stephen Hull
Principal and Founder
Hull Associates
James Turnbull
Senior Vice President, Omnichannel & Digital
OPEN Health
Christina Hoffman
Global Head, Medscape Medical Affairs
Medscape Medical Affairs
Alessandro Pontes-Arruda
Vice-President, U.S. Medical Head Cardiovascular and Established Products
Sanofi
Gokhan Tanju
Executive Director, Business Intelligence
Medscape Medical Affairs
Luke Rogers
Senior Director, Business Partnerships
Within3
Eric Noehrenberg
President
NIPC
Luke Rogers
Senior Director, Business Partnerships
Within3
Innovation in an already crowded oncology space has created a challenge for medical affairs. The proliferation of compounds in development has reinforced the need to accurately identify strategic opportunities, address the scientific need of experts, while continuously demonstrating value. To achieve these goals, medical leaders must develop clear, comprehensive insights. With an immense amount of data at their disposal, medical affairs must develop novel approaches to leverage this information to inform targeted decisions and investments.
Robert Groebel
Vice President - Global Medical Strategy
Monocl
Luke Rogers
Senior Director, Business Partnerships
Within3
Gemma Allen
Head of Digital Communications
Open Health
Luke Rogers
Senior Director, Business Partnerships
Within3
Joachim Flickinger
Head of Clinical & Patient Markets
Karger Publishers, Switzerland
Iola Gulijew
Strategic Competence Lead, Industry & Society Services
Karger Publishers, Switzerland
Within3 offers a virtual engagement platform that gives stakeholders the freedom to communicate anytime, anywhere, on any device
Luke Rogers
Senior Director, Business Partnerships
Within3
Luke Rogers
Senior Director, Business Partnerships
Within3
Helen Kane
Founder & Managing Director
ONE MSL, UK
Sergio Diaz
Patient-Centred Outcomes Consultant
OPEN VIE
Amanda Pulfer
Strategic Director
OPEN VIE
Jeremy Rassen
President and Chief Science Officer
Aetion, USA